Browse by Authors and Editors
Number of items: 2. Ghaneh, Paula, Hanson, Robert, Titman, Andrew, Lancaster, Gill, Plumpton, Catrin, Lloyd-Williams, Huw, Tien Yeo, Seow, Edwards, Rhiannon T., Johnson, Colin, Hilal, Mohammed Abul., Higginson, Antony P., Armstrong, Tom, Smith, Andrew, Scarsbrook, Andrew, McKay, Colin, Carter, Ross, Sutcliffe, Robert P., Bramhall, Simon, Kocher, Hemant M., Cunningham, David, Pereira, Stephen P., Davidson, Brian, Chang, David, Khan, Saboor, Zealley, Ian, Sarker, Debashis, Al Sarireh, Bilal, Charnley, Richard, Lobo, Dileep N., Nicolson, Marianne, Halloran, Christopher, Raraty, Michael, Sutton, Robert, Vinjamuri, Sobhan, Evans, Jonathan, Campbell, Fiona, Deeks, Jon, Sanghera, Bal, Wong, Wai-Lup and Neoptolemos, John P. (2018) PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. Health Technology Assessment, 22 (7). ISSN 1366-5278 Middleton, Gary, Palmer, Daniel H., Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony, Shaw, Victoria E., Wadsley, Jonathan, Valle, Juan W., Propper, David, Wasan, Harpreet, Falk, Stephen, Cunningham, David, Coxon, Fareeda, Ross, Paul, Madhusudan, Srinivasan, Wadd, Nick, Corrie, Pippa, Hickish, Tamas, Costello, Eithne, Campbell, Fiona, Rawcliffe, Charlotte and Neoptolemos, John P. (2017) Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. Lancet Oncology, 18 (4). pp. 486-499. ISSN 1474-5488 |
